ARCHIVES

More Debate Due On Organ Site Program; First Round Reviewed By DRG “Slaughtered”

This article is from The Cancer Letter archive.

Vol. 09 No. 04 | January 28, 1983

Download PDF Visit The Full Archive

Related Articles

In Brief: Hammond Resigned As ACS Officer; Wykoff Slated To Direct FDA Special Populations Office

November 20, 1992

Trading In Stock Of U.S. Bioscience Halted, Newsletter Report Cited

October 9, 1992

White House Defers to Pressure, Gives Up Attempt to Cut NIH Budget $334 Million In ‘87

March 6, 1987

NCI Revises Procedure for Contract Concept Review By Advisors

September 6, 1996

Sanofi: Zaltrap Price Reflects Competing Drugs In Second-Line Metastatic Colon Cancer

November 1, 2012

Revlimid Shows 91 Percent Response in Non-Hodgkin’s

July 29, 2011